Birchview Capital as of Dec. 31, 2015
Portfolio Holdings for Birchview Capital
Birchview Capital holds 40 positions in its portfolio as reported in the December 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 53.5 | $93M | 776k | 119.76 | |
Accelr8 Technology | 26.7 | $46M | 2.2M | 21.49 | |
Vermillion | 2.8 | $4.9M | 2.7M | 1.80 | |
Metabolix | 1.8 | $3.1M | 2.3M | 1.39 | |
Contrafect | 1.3 | $2.3M | 475k | 4.75 | |
EQT Corporation (EQT) | 1.3 | $2.2M | 42k | 52.13 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.9 | $1.6M | 59k | 27.50 | |
Medivation | 0.9 | $1.6M | 33k | 48.35 | |
Masimo Corporation (MASI) | 0.9 | $1.5M | 37k | 41.50 | |
Neurocrine Biosciences (NBIX) | 0.8 | $1.3M | 23k | 56.55 | |
Oncomed Pharmaceuticals | 0.8 | $1.3M | 59k | 22.54 | |
Hansen Medical | 0.7 | $1.2M | 528k | 2.33 | |
Biolase Technology | 0.6 | $1.1M | 1.3M | 0.84 | |
Quotient | 0.5 | $931k | 58k | 16.00 | |
Kura Oncology (KURA) | 0.5 | $884k | 105k | 8.40 | |
Quidel Corporation | 0.5 | $826k | 39k | 21.19 | |
Merck & Co (MRK) | 0.5 | $792k | 15k | 52.80 | |
Wright Medical | 0.4 | $725k | 30k | 24.17 | |
Encana Corp | 0.4 | $673k | 132k | 5.09 | |
Accuray Incorporated (ARAY) | 0.4 | $643k | 95k | 6.75 | |
NxStage Medical | 0.3 | $563k | 26k | 21.91 | |
Cerus Corporation (CERS) | 0.3 | $525k | 83k | 6.33 | |
Ptc Therapeutics I (PTCT) | 0.3 | $483k | 15k | 32.42 | |
Oxford Immunotec Global | 0.3 | $463k | 40k | 11.49 | |
Corcept Therapeutics Incorporated (CORT) | 0.2 | $398k | 80k | 4.98 | |
Gilead Sciences (GILD) | 0.2 | $387k | 3.8k | 101.31 | |
Pioneer Natural Resources (PXD) | 0.2 | $376k | 3.0k | 125.33 | |
Sientra | 0.2 | $375k | 63k | 5.92 | |
Cabot Oil & Gas Corporation (CTRA) | 0.2 | $371k | 21k | 17.67 | |
Tesaro | 0.2 | $364k | 7.0k | 52.37 | |
Advaxis | 0.2 | $358k | 36k | 10.06 | |
Biogen Idec (BIIB) | 0.2 | $306k | 1.0k | 306.00 | |
Transition Therapeutics | 0.2 | $280k | 146k | 1.92 | |
Celgene Corp right 12/31/2011 | 0.2 | $286k | 238k | 1.20 | |
Merrimack Pharmaceuticals In | 0.1 | $237k | 30k | 7.90 | |
Agios Pharmaceuticals (AGIO) | 0.1 | $221k | 3.4k | 65.00 | |
Raptor Pharmaceutical | 0.1 | $208k | 40k | 5.20 | |
Roka Bioscience | 0.1 | $187k | 152k | 1.23 | |
Xencor (XNCR) | 0.1 | $180k | 12k | 14.63 | |
Coherus Biosciences (CHRS) | 0.1 | $172k | 7.5k | 22.93 |